ClinicalTrials.gg
Biological

CHO cell clinical trials

studies test it
35
open now
7
in phase 3
13
first study started
2019

How each study uses CHO cell is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the CHO cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Recombinant new coronavirus vaccine (CHO cell) group
5
Recombinant Zoster Vaccine (CHO Cell)
4
Recombinant two-component COVID-19 vaccine (CHO cell)
3
Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)
3
ReCOV
2

Development codes

REC610
1

Studies by the year they started

35 studies that test it; most in 2021 (11)

Studies that test CHO cell, by start year
YearStudies
20191
20205
202111
20227
20231
20242
20253
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
10
Phase 2
11
Phase 3
13
Phase 4
1
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 5

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (12) · MAXVAX Biotechnology Limited Liability Company (5) · Jiangsu Rec-Biotechnology Co., Ltd. (5) · Ab&B Bio-tech Co., Ltd.JS (2) · National Vaccine and Serum Institute, China (2) · Guangzhou Patronus Biotech Co., Ltd. (2) · Jiangsu Province Centers for Disease Control and Prevention (2) · Shenyang Sunshine Pharmaceutical Co., LTD. (2)

Often tested with

Tested in the same studies.

CHO Cells (3) · Adjuvant (1) · Vero cell line (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test CHO cell.

Studies

Open first, then newest update. How each study uses CHO cell is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 35

See all 35 studies that test CHO cell →

Given beside what is tested · 1 — CHO cell is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with CHO cell

What changed recently

From the registry's own updates since Oct 17, 2026.